Veľké Lovce

EuroEyes Delivers Solid Results in 2022

Retrieved on: 
Tuesday, March 28, 2023
Momentum, Veľké Lovce, San Francisco Chinese New Year Festival and Parade, Travel, Russell Street, Marketing, 2016 EuroEyes Cyclassics, LEC, ICL, HK, COVID-19, LVCP, EBIT, HKD, Republic, EBITDA, Acquisition, Patient, Hong Kong dollar, Chinese New Year, Ophthalmology, United Kingdom, Depreciation, City, Yoy, Relaxation, Retail, Video game, Pharmaceutical industry, PRC, Causeway Bay, Euro

EuroEyes is pleased to announce its annual results for the year ended 31 December 2022 (the "Year").

Key Points: 
  • EuroEyes is pleased to announce its annual results for the year ended 31 December 2022 (the "Year").
  • EuroEyes faced a challenging year in 2022 due to the unfavourable macro environment created by the global COVID-19 pandemic and its related control policies, as well as geopolitical turmoil, inflation and currency fluctuations.
  • In 2022, the Group's total revenue was approximately EUR74.0 million, representing an increase of approximately 7.5% YoY (HK$ equivalent: 610.3 million).
  • EuroEyes announced the acquisition of the London Vision Clinic ("LoVC") on 20 January 2022 for a completion consideration of GBP13,130,000.

EuroEyes Acquires 100% Issued Shares in London Vision Clinic Partners Limited

Retrieved on: 
Friday, January 28, 2022
Growth, Diagnosis, CEO, Eye, Safety, Patient, Financial assistance (share purchase), BlueFocus Communication Group, EBIT, Stock exchange, Relex, Presbyopia, Acquisition, Partner, SMILE, Company, Biostatistics, Ophthalmology, ICL, London Stock Exchange Group, Invention, Industry, OCT, GBP, Completion, ICRS, Surgeon, Dentistry, News, Sales, Group, LASIK, 2016 EuroEyes Cyclassics, PRC, PRK, Veľké Lovce

The shareholding will serve as an share incentive to motivate and retain London Vision Clinic's partners and key surgeons.

Key Points: 
  • The shareholding will serve as an share incentive to motivate and retain London Vision Clinic's partners and key surgeons.
  • London Vision Clinic Partners Limited is one of the leading brands in the vision correction industry and principally engaged in the provision of premium vision correction services, including PRK, LASIK, SMILE, phakic lens (ICL) surgery and refractive cataract surgery.
  • Professor Reinstein will be one of the key speakers and trainers at London Vision Clinic Training.
  • Issued by Porda Havas International Finance Communications Group for and on behalf of EuroEyes International Eye Clinic Limited.